AYTU

NASDAQ -> Healthcare -> Drug Manufacturers - Specialty & Generic

Denver, United States

Type: Equity

Aytu Boosts Liquidity with Eclipse Loan Extension

Insider Monkey · via Yahoo Finance 6 Jul 2025

CEO & Director of Aytu BioPharma Joshua Disbrow Buys 77% More Shares

Simply Wall St. · via Yahoo Finance 12 Jun 2025

Aytu BioPharma Inc (AYTU) Q2 2025 Earnings Call Highlights: Strong Cash Position...

GuruFocus.com · via Yahoo Finance 8 Feb 2025

Aytu BioPharma Proposes Settlement in Shareholder Lawsuit

TipRanks · via Yahoo Finance 8 Dec 2024

Aytu BioPharma Inc (AYTU) Q1 2025 Earnings Call Highlights: A Historic Quarter...

GuruFocus.com · via Yahoo Finance 7 Nov 2024

It's Unlikely That The CEO Of Aytu BioPharma, Inc. (NASDAQ:AYTU) Will See A Huge...

Simply Wall St. · via Yahoo Finance 12 Jul 2024

Aytu BioPharma, Inc. (NASDAQ:AYTU) Q2 2024 Earnings Call Transcript

Insider Monkey via Yahoo Finance 16 Feb 2024

Loss-Making Aytu BioPharma, Inc. (NASDAQ:AYTU) Expected To Breakeven In The Medium-Term

Simply Wall St. via Yahoo Finance 9 Aug 2023

There's No Escaping Aytu BioPharma, Inc.'s (NASDAQ:AYTU) Muted Revenues

Simply Wall St. · via Yahoo Finance 12 Jul 2023